Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study

(1) Background: Metastatic L-type sarcomas (liposarcoma and leiomyosarcoma) are rare and have a poor prognosis. Trabectedin is an effective agent that can be used after anthracyclines. This study was designed to evaluate the real-life effectiveness and safety of trabectedin. (2) Methods: A retrospec...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sercan Ön, Barış Köksal, Zafer Arık, Burcu Caner, Duygu Ercan Uzundal, Ozan Yazıcı, Burcu Arslan Benli, Eda Eylemer Mocan, Can Güngör, Zeynep Gülsüm Güç, Seval Akay, Merve Keskinkılıç, Hande Dik Avcı, Burçak Karaca Yayla, Burcu Çakar, Ulus Ali Şanlı
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Current Oncology
Subjects:	liposarcomas leiomyosarcomas ecteinascidin 743 trabectedin drug toxicity targeted radiation therapy
Online Access:	https://www.mdpi.com/1718-7729/31/11/502
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study

Similar Items